Regulated exocytosis, which underlies many intercellular signaling events, is a tightly controlled process often triggered by calcium ions (Ca 2+ ). Despite considerable insight into the central components involved, namely the core fusion machinery (soluble N-ethylmaleimide-sensitive factor attachment protein receptor, SNARE) and the principal Ca 2+ sensor (C2 domain proteins, like Synaptotagmin), the molecular mechanism of Ca 2+ -dependent release has been unclear.
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Timely secretion of a variety of critical molecules, including neurotransmitters, hormones and enzymes, are achieved via regulated exocytosis (1) (2) (3) . During regulated exocytosis, the secretory vesicles fuse to the plasma membrane (PM) in response to an external stimuli, typically activated by Ca 2+ influx. However, SNARE proteins, which catalyze the fusion of the cargo-carrying vesicles, are constitutively active (4, 5) . When the cognate pair of SNAREs located on the vesicle (v-SNARE) and the target membrane (t-SNARE) are in molecular proximity, they readily assemble into a stable complex providing the energy to fuse the membranes (4, 5) . Thus, regulated exocytosis requires mechanisms both to prevent the spontaneous fusion of vesicles ('clamping') under rest and to transduce the Ca 2+ signal into activating the clamped fusion machinery (1-3).
Synaptotagmins (Syt), a family of tandem C2-domain (C2A & C2B) containing protein that bind both Ca 2+ ions and SNARE proteins (3, (6) (7) (8) (9) (10) , play a critical role in this processes. The Ca 2+ activation mechanism has been well-characterized and involves the insertion of surface loops on each of the C2 domains into the membrane bilayer with Ca 2+ coordinating it to acidic lipids, phosphatidylserine (PS) and phosphatidylinositol 4,5-bisphosphate (PIP2) (11) (12) (13) (14) (15) (16) . But, how the constitutive fusion is arrested to enable the Ca 2+ -coupled exocytosis is not known. Nevertheless, Syt is believed to play a crucial role in this process as deletion (or mutations) of Syt1 (the neuronal isoform), in addition to eliminating the Ca 2+ -dependent release, also increases the normally small rate of spontaneous exocytosis (8, 17) .
New details on the spatial organization of Syt1 (and related C2 domain proteins) have recently emerged, which could potentially describe its dual role in orchestrating regulated exocytosis (18) (19) (20) (21) . Isolated Syt1 was discovered to polymerize into ~30 nm (diameter) sized ring-like oligomers, prompted by the binding of polyvalent anions, like ATP in solution or PS/PIP2 on membranes, to a conserved polylysine motif within the C2B domain (19) (20) (21) . Moreover, the ring-shaped oligomers formed on membranes are sensitive to Ca 2+ and rapidly disassemble at physiological Ca 2+ concentration. This is because the same surface on the C2B domain that is used to form the ring, binds Ca 2+ and reorients into the lipid bilayer (19, 21) . If these C2B derived Syt1 oligomers were to form at the site of docking, then they could potentially regulate the terminal phases of vesicular release (18) . While there is yet no direct evidence that such ring oligomers exist in vivo, salient genetic and biochemical correlates provided by the oligomeric structure (19, 21) and the structural conservation of circular oligomerization among many C2 domain protein (21) strongly support the overall hypothesis.
In this report, we examine the physiological role of the Syt1 oligomers using a targeted mutation (F349A) that specifically disrupts the C2B-dependent oligomerization. We find that the destabilizing the Syt1 oligomers uncouples vesicular release from Ca 2+ -influx in PC12 cells, even though the Ca 2+ -sensing capacity and other molecular properties of Syt1 are unaltered. Our data suggests that the Syt1 oligomerization represent a central organizing principle for Ca 2+ -coupled exocytosis in PC12 cells and may very well represent a universal mechanism underlying Ca 2+ -regulated exocytosis under diverse settings.
RESULTS

Identification of Syt1 Ring Oligomer Disrupting Mutation
To test the functional role of the Syt1 oligomers, we sought to generate targeted mutations in Syt1 that specifically disrupt its C2B dependent oligomerization. Based on fitting the X-ray crystal structure of Syt1 C2AB (residues 143-421) into the EM density map generated from the reconstruction of the Syt1 C2AB coated tubes (19) (See SI Appendix, Fig. S1A ), we identified putative residues in the C2B domain (Val-304, Leu-307, Tyr-311, Phe-349, Leu-394) likely to be involved in mediating Syt1 ring oligomer assembly (Fig. 1A) . Given the hydrophobic nature of the dimer interface ( Figure 1A ), we systematically assessed the effect of polar (Asn) mutation on oligomer assembly using electron microscopy (EM) analysis as described previously (19, 21) .
Briefly, the lipid monolayer (PC/PS at 3:2 molar ratio) formed at the air/water interface was recovered on a carbon-coated EM grid and protein solution was added to the lipid monolayer under Ca 2+ -free conditions (1 mM EDTA) and incubated for 1 min at 37˚C. Negative stain analysis revealed that polar (Asn) mutation of two key hydrophobic residues (Leu-307 & Phe-349) has a strong effect, with near complete elimination of Syt1 C2AB oligomeric structures (Fig. 1B & 1C ).
Similar mutation of other putative residues had little or no effect on the Syt1 C2AB polymerization (Fig. 1B & 1C) . In fact, replacing Leu-307 or Phe-349 with a weak hydrophobic residue, like Alanine (L307A or F349A), was sufficient to disrupt the oligomer formation (Fig. 1B, 1C ). Given the conservative nature of the Ala replacement and lower probability of off-target effects, we chose these mutations for further analysis.
F349A Mutation Selectively Affects Syt1 Oligomerization
To evaluate the specificity of the identified mutations, we examined the effect of L307A (Syt1  L307A ) and F349A mutation (Syt1 F349A ) on distinct molecular properties of Syt1 (Fig. 2) (Fig. 2D) . So, we conclude that F349A mutation selectively impairs Syt1 oligomerization without affecting other critical molecular properties. Further underscoring its effectiveness, the F349A mutation also disrupted the ring oligomer formation of the entire cytoplasmic domain of Syt1 (residues 96-421) under physiological lipid and buffer conditions (See SI Appendix, Fig. S1B ).
F349A Mutation Eliminates Ca 2+ -control of exocytosis in PC12 cells
We assessed the effect of the F349A mutation on vesicular exocytosis using rat adrenal pheochromocytoma (PC12) cells, a widely used model system for studying neurosecretion (25, 26 (Fig. 3C ), hinting at possible impairment of vesicle docking/priming process. This was confirmed by EM data showing a significant reduction of vesicle density in the immediate vicinity of the plasma membrane in the F7 cells (Fig. 3D) .
Overexpression of Syt1 WT in this background partially rescued vesicle docking (Fig. 3D ) and restored the fusion properties to the control levels ( Fig. 3C) (Fig. 3C) . Nonetheless, the number of constitutive exocytotic events was still significantly higher compared to the Syt1 WT rescue conditions (Fig. 3C ). This implies that the significant portion of the exocytotic events observed with Syt1 F349A rescue are constitutive-in-nature (i.e. Ca 2+ -independent), even under Ca 2+ -stimulating conditions.
To verify that the observed phenotype under Syt1 Consistent with the fusion phenotype, we also observe clear deficiency in docking of the dense core vesicles in the untransfected F7 cells (Fig. 3D ). It is worth noting that in our experimental conditions overexpression of Syt1 WT was able to partially rescue the docking phenotype and fully restore the fusion properties, including the Ca 2+ -regulated exocytosis, to the control PC12 cell levels ( Fig. 3 ). This provides an ideal background to relate the effect of disrupting the oligomer formation using the Syt1 F349A mutant.
We further note that the observed effect of the Syt1 deficiency appears to be highly dependent on the choice of the reporter. Syt1 deficiency has been shown to: increase the release of dopamine/ATP (27), have no effect or drastically reduce the release of norepinephrine (32), reduce the release of catecholamines, and abolish NPY release (37, 38). In the current study, we use VAMP2-pHluorin, a universal reporter for exocytosis from all types of vesicles in PC12 cells.
We additionally confirmed our fusion phenotype for untransfected and for both WT and F349A rescue conditions using independent reporters, Synaptophysin-pHluorin and NPY-pHluorin specific for small, clear vesicles and dense core vesicles, respectively (See SI Appendix, Fig. S3 ).
How does the Syt1 oligomerization reversibly clamp fusion? We envision a concerted mechanism wherein the full complement (15-20 copies) of Syt1 on the vesicle oligomerize at the site of docking triggered by PIP2 binding (Fig. 4) . It is then ideally positioned to simultaneously template multiple SNAREpins, likely using the recently identified 'primary' binding site involving SNAP25
and C2B domain (9, 18) , which is accessible and free to interact in the ring oligomer (21). The height of Syt1 oligomers combined with the SNAREs atop would maintain the two bilayers far apart (~4 nm) to allow the N-terminal assembly but sterically block the complete assembly (18) .
The SNAREpin bound to the Syt1 ring oligomer would also be restrained from moving radially inwards in the membrane plane, preventing full-zippering (18) . In this manner, the Syt1 oligomerization lowers the probability of the fusion of the docked vesicle in the absence of the Ca 2+ -trigger (Fig. 4) .
It is possible that the C2B oligomers dynamically break and re-form, and intact ring-like oligomers observed in vitro are not always present or predominate in vivo. Under these conditions, very short oligomers of Syt1 could serve to clamp SNAREpins by restraining them from rotating away from the ideal orientation in which C-terminal zippering is sterically prevented. However, such a stochastic mechanism would produce an inefficient clamp as the SNAREpin can 'twist' out position and complete zippering, leading to fusion (18) . Thus, we favor a more concerted mechanism, in which in the Syt1 ring-like oligomers acts as a 'primer' to template and link multiple SNARE proteins, and along with the SNARE-associated chaperones (Munc13 & Munc18) and regulators (Complexin) enable rapid, Ca 2+ -coupled vesicular release (18) . Additionally, this arrangement would allow for binding of other Syt isoforms to the templated SNARE proteins via the conserved Complexin-dependent 'tripartite' binding site (10) and, thus provides a plausible framework to describe the synergistic action of different Syt isoforms (39) . While precise molecular architecture of the clamped state is still unclear, the Syt1 oligomer-based model provides the most elegant solution of a symmetrical structure that balances the physical forces to maximize stability prior to release (18 role. This is an emerging and speculative concept (18, 42) and requires further research.
While the clustering of synaptotagmin at nerve terminals has been reported (43), the oligomeric structures (intact or dynamic) that we propose have not been directly observed. We note that the methods applied to date under both in vivo and in vitro, would not be expected to reveal these structures without intentional effort, in particular to preserve these metastable structures. Thereby, focused high-resolution structural studies within the cellular context will be needed to confirm the general outline of this model and to provide intimate details. Nevertheless, given C2-domain oligomerization is a conserved feature among C2-domain proteins (21), many of which regulate exocytosis, we believe that diverse forms of intercellular communications and physiological response may also rely on similar clamping and triggering mechanism to govern the fusion machinery.
EXPERIMENTAL PROCEDURES
Materials. The following DNA constructs, which have been previously generated and sequenced Proteins were rapidly diluted to 3 μM in 20 mM MOPS, pH 7.5, 15 mM KCl, 1 mM EDTA, 2 mM MgAC2, 1 mM DTT, 5% (wt/vol) trehalose buffer and then added to the lipid monolayer on the grid and incubated in a 37°C humidity chamber for 1 min. The final KCl concentration in the buffer was adjusted to 100 mM as required. To facilitate structural analysis of the ring-like structrures, we further optimized the incubation conditions by using an annealing procedure: rings were nucleated at 37°C for 1 min followed by a 30-min annealing step at 4 °C. The grids were rinsed briefly (∼10 s) with incubation buffer alone or with buffer supplemented with CaCl2 (0.1, 0.5 and 1 mM free)
for Ca2+ treatment studies. The free [Ca2+] was calculated by Maxchelator (maxchelator.stanford. edu). Subsequently, the grids were blotted with Whatman#1 filter paper, negatively stained with uranyl acetate solution (1% wt/vol), and air dried. The negatively stained specimens were examined on a FEI Tecani T12 operated at 120 kV. The defocus range used for our data was 0.6-2.0 μm. Images were recorded under low-dose conditions (∼20 e−/Å 2 ) on a 4K × 4K CCD camera (UltraScan 4000; Gatan, Inc.), at a nominal magnification of 42,000×.
Micrographs were binned by a factor of 2 at a final sampling of 5.6 Å per pixel on the object scale.
The image analysis, including size distribution measurements, was carried out using Image J software.
Liposome Flotation Assay. Ca 2+ -independent Syt1-membrane interaction was measured using a liposome floatation assay as described previously (21). Syt1 CD (WT & F349A) were incubated with PS/PIP2 liposomes (71.5% PC, 25% PS, 2.5% PIP2,1% NBD) for 1h at room temperature and separated using a discontinuous Nycodenz (Sigma-Aldrich, St. Louis, MO) gradient. The bound fraction (normalized to the lipid using NBD-fluorescence) was then estimated using densitometry analysis of SDS-PAGE gels using Image J software (45 labeled with an environment-sensitive probe, NBD. Stopped-flow rapid mixing analysis was carried out using Applied Photophysics SX20 instrument (Applied Photophysics Ltd, Surrey, UK)
as described previously (13) independent experiments, in all cases the expression levels were normalized to the endogenous levels in control PC12 cells. Figure S3 . Effect on disrupting the Syt1 oligomerization using F349A mutation on the exocytosis of small, clear vesicles and large, dense core vesicles were assessed using the (A) Synaptophysin-pHluorin and (B) NPY-pHluorin (B) respectively. In both cases, single vesicle fusion events under basal (constitutive) and KCl-depolarized (Ca 2+ -stimulated) conditions were imaged using TIRF microscopy.
Consistent with the universal VAMP2-pHluorin marker (Fig. 3C ), Syt1 F349A expression specfically enhances the basal, constitutive fusion and occludes Ca 2+ -control of neuroexocytosis when compared to Syt1 WT transfected F7 cells for both the independent vesicle markers.
These result further supports the notion the observed phenotype is specifically caused by disruption of C2B-dependent Syt1 oligomerization and is not due to off-target effect of Syt1 349A expression.
